Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by the hepatic deficiency of porphobilinogen deaminase (PBGD) and the slowdown of heme biosynthesis. AIP symptomatology includes life-threatening, acute neurovisceral or neuropsychiatric attacks manifesting in response to pre...

Full description

Bibliographic Details
Main Authors: Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
AIP
PBGD
heme
liver metabolism
α-lipoic acid
insulin
Online Access:https://www.mdpi.com/2227-9059/10/3/648

Internet

https://www.mdpi.com/2227-9059/10/3/648

Similar Items